User Name Password

back to homepage

SilverCrest Mining (SVL.V) - revised valuation of C$1.32 per share

Full Report by Objective Capital , Sep 22, 2008 (login for full report)
Click for previous reports on this company
Questions? Contact our analyst

Key Points:

  • Santa Elena now hosts a mining reserve sufficient for eight years’ production
    SilverCrest’s recently completed pre-feasibility study incorporates an NI 43- 101-compliant proven and probable mining reserve of 6.54 million tonnes, averaging 1.61 grams of gold and 56.7 grams of silver per tonne. The company has an additional indicated and inferred mineral resource of 4.07 million tonnes, averaging 1.52 grams of gold and 91.2 grams of silver.

  • SilverCrest envisages a 2,500-tonne-per-day mine at Santa Elena
    SilverCrest’s preliminary mine plan calls for a 2,500-tonne-per-day open pit, heap leach operation at Santa Elena. Based on expected recovery rates, the pre-feasibility study projects the mine will produce 30,000 ounces of gold and 500,000 ounces of silver annually.

  • Gold and silver prices retreat, but remain robust
    The price of gold has retreated to just over US$800 per ounce after briefly topping US$1,000 per ounce earlier this year, but remains well above its longterm, inflation-adjusted average of US$550 per ounce (in current dollars). At US$13.70 per ounce, silver is also well above its long-term, inflation-adjusted mean of US$6.75, although sharply lower than prices noted early this summer.

  • Cost projections remain modest, supporting an expected high rate of return
    SilverCrest’s pre-feasibility study projects the capital cost of the proposed Santa Elena mine at US$20m, including provisions for contingencies and working capital. The cash operating costs are projected at US$328 per ounce in current dollars, and less than US$250 per ounce over the first two years, providing a quick payback.

  • Valuation modestly lower but more robust on gathering confidence
    Our revised model places a base-case value of C$1.32 per share on SilverCrest Mines, slightly lower than our C$1.39 initiation note estimate of February 2008 and the result of several counter-veiling influences. Most prominently, the completion of the pre-feasibility study has increased our confidence in success at Santa Elena, whilst the dilutive effect of a large equity placement exerted a significant negative influence. Our more optimistic assessment of C$1.48 per share is based on higher probabilities of exploration success, reflecting the potential offered by further drilling.

Free registration required for full report

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer